2016 Jun;18(6):29. doi: 10.1007/s11940-016-0407-4.
Vezyroglou K1, Cross JH2,3.
Abstract
OPINION STATEMENT:
The mainstay of treatment of epilepsy has been antiepileptic drugs; however, despite the emergence of new agents, a consistent proportion remain drug-resistant. Newer AEDs show promise. However, as it becomes clear that the epilepsies are a group of diseases rather than a single disorder the prospect of targeted treatment in some may become a reality.
KEYWORDS:
Antiepileptic drugs (AED); Cannabidiol (CBD); Childhood epilepsies; Epileptic encephalopathy; Ketogenic diet (KD); Next generation sequencing (NGS); Targeted therapy
- PMID:
- 27154366
- [PubMed]
-
Publication Types
